Index
| Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
|
ACRad16
|
Report Turnaround Time: Ultrasound (Excluding Breast US)
(Inverse Measure)
|
|
Outcome |
|
|
|
|
|
|
ACRad17
|
Report Turnaround Time: MRI
(Inverse Measure)
|
|
Outcome |
|
|
|
|
|
|
ACRad18
|
Report Turnaround Time: CT
(Inverse Measure)
|
|
Outcome |
|
|
|
|
|
|
ACRad19
|
Report Turnaround Time: PET
(Inverse Measure)
|
|
Outcome |
|
|
|
|
|
|
ACRad2
|
CT Colonography Clinically Significant Extracolonic Findings (Inverse Measure)
|
|
Outcome |
|
|
|
|
|
|
ACRad21
|
Lung Cancer Screening Cancer Detection Rate (CDR)
|
|
Outcome |
|
|
|
|
|
|
ACRad22
|
Lung Cancer Screening Positive Predictive Value (PPV)
|
|
Outcome |
|
|
|
|
|
|
ACRad23
|
Lung Cancer Screening Abnormal Interpretation Rate
|
|
Outcome |
|
|
|
|
|
|
ACRad25
|
Report Turnaround Time: Mammography
|
|
Outcome |
|
|
|
|
|
|
ACRad26
|
Appropriate venous access for hemodialysis
|
|
Process |
|
|
|
|
|
|
ACRad27
|
Uterine artery embolization technique: Documentation of angiographic endpoints and interrogation of ovarian arteries
|
|
Process |
|
|
|
|
|
|
ACRad28
|
Rate of early peristomal infection following fluoroscopically guided gastrostomy tube placement
|
|
Outcome |
|
|
|
|
|
Page 12 of 75